Visualizing the innate and adaptive immune response to Listeria monocytogenes

可视化对单核细胞增生李斯特氏菌的先天和适应性免疫反应

基本信息

项目摘要

DESCRIPTION (provided by applicant): Listeria monocytogenes (LM) infection generates a robust innate and adaptive immune response. As a result, several attenuated stains of recombinant LM are being investigated as vaccine vehicles. However, compared to infection with live-LM, immunization with attenuated or killed LM vaccines fails to induce protective cell mediated immunity. Potent activation of the innate immune response is necessary for the robust priming and differentiation of a protective CD8 T cell response. The precise cellular mechanisms that drive a productive vs. a poorly-productive immune response are not well understood. Mounting a protective immune response is dependent on the orchestrated movement of cells within lymphoid organs. This movement is carefully regulated by several factors including host-pathogen interactions and the highly organized lymphoid structure. The cellular mechanisms that control the temporal events that lead to the robust activation of the innate immune system that subsequently induce pathogen-specific cell mediated immunity are poorly understood. In particular, the role of host-pathogen interactions and their geographical localization within a lymphoid organ is poorly defined. Understanding how pathogens interact with immune cells in vivo is important to develop effective and safe microbial based vaccines. Here, we will use distinct immunization models to test the overall hypothesis that changes in the cellular niche of Listeria control the temporal compartmentalization of the bacteria in the spleen. The splenic localization of LM in turn regulates innate immune cell recruitment, local migration and differentiation. The proper progression of these hierarchical events ultimately dictates the outcome of the protective adaptive immunity rendered against the pathogen. In this proposal we will visualize an effective vs. an ineffective anti-microbial immune response with the goal of identifying the pivotal checkpoint(s) of an immune response that lead to protective immunity in vivo. Based on our preliminary data and published studies we propose the following aims: 1) To determine the cellular tropism, localization and antigen presentation after immunization with live-LM or attenuated LM strains. 2) To determine the anatomical mechanisms surrounding ineffectual vaccination. 3) To Determine the cellular mechanisms for the splenic trafficking of live-LM and bacterial antigens in vivo.
描述(由申请方提供):单核细胞增生李斯特菌(LM)感染产生强大的先天性和适应性免疫应答。因此,正在研究重组LM的几种减毒菌株作为疫苗载体。然而,与用活LM感染相比,用减毒或灭活LM疫苗免疫不能诱导保护性细胞介导的免疫。先天免疫反应的有效激活对于保护性CD 8 T细胞反应的稳健引发和分化是必要的。驱动生产性与生产性差的免疫反应的精确细胞机制尚未得到很好的理解。建立保护性免疫应答依赖于淋巴器官内细胞的协调运动。这种运动受到多种因素的精心调控,包括宿主-病原体相互作用和高度组织化的淋巴结构。控制时间事件的细胞机制,导致先天免疫系统的强大激活,随后诱导病原体特异性细胞介导的免疫力知之甚少。特别是,宿主-病原体相互作用及其在淋巴器官内的地理定位的作用定义不清。了解病原体在体内如何与免疫细胞相互作用对于开发有效和安全的微生物疫苗非常重要。在这里,我们将使用不同的免疫模型来测试总体假设,即李斯特菌细胞生态位的变化控制脾脏中细菌的时间区室化。LM的脾定位反过来调节先天免疫细胞的募集、局部迁移和分化。这些分级事件的适当进展最终决定了针对病原体的保护性适应性免疫的结果。在本提案中,我们将可视化有效与无效的抗微生物免疫应答,目的是确定导致体内保护性免疫的免疫应答的关键检查点。基于我们的初步数据和已发表的研究,我们提出以下目的:1)确定LM活株或减毒株免疫后的细胞嗜性、定位和抗原呈递。 2)确定无效疫苗接种的解剖学机制。 3)确定活体LM和细菌抗原在体内脾脏运输的细胞机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kamal Mohan Khanna其他文献

Kamal Mohan Khanna的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kamal Mohan Khanna', 18)}}的其他基金

The role of CX3CR1+ CD4+ T cells during helminth infection
CX3CR1 CD4 T细胞在蠕虫感染过程中的作用
  • 批准号:
    10083698
  • 财政年份:
    2020
  • 资助金额:
    $ 36.19万
  • 项目类别:
Novel lung resident interstitial macrophage subset with distinct localization and polarization
具有独特定位和极化的新型肺驻留间质巨噬细胞亚群
  • 批准号:
    10265792
  • 财政年份:
    2020
  • 资助金额:
    $ 36.19万
  • 项目类别:
Novel lung resident interstitial macrophage subset with distinct localization and polarization
具有独特定位和极化的新型肺驻留间质巨噬细胞亚群
  • 批准号:
    10320372
  • 财政年份:
    2019
  • 资助金额:
    $ 36.19万
  • 项目类别:
Novel lung resident interstitial macrophage subset with distinct localization and polarization
具有独特定位和极化的新型肺驻留间质巨噬细胞亚群
  • 批准号:
    10540720
  • 财政年份:
    2019
  • 资助金额:
    $ 36.19万
  • 项目类别:
Novel lung resident interstitial macrophage subset with distinct localization and polarization
具有独特定位和极化的新型肺驻留间质巨噬细胞亚群
  • 批准号:
    10327097
  • 财政年份:
    2019
  • 资助金额:
    $ 36.19万
  • 项目类别:
Mechanisms controlling memory CD8 T cell recognition of autoantigen
控制记忆 CD8 T 细胞识别自身抗原的机制
  • 批准号:
    8890780
  • 财政年份:
    2014
  • 资助金额:
    $ 36.19万
  • 项目类别:
Visualizing the innate and adaptive immune response to Listeria monocytogenes
可视化对单核细胞增生李斯特氏菌的先天和适应性免疫反应
  • 批准号:
    8219664
  • 财政年份:
    2012
  • 资助金额:
    $ 36.19万
  • 项目类别:
Visualizing the innate and adaptive immune response to Listeria monocytogenes
可视化对单核细胞增生李斯特氏菌的先天和适应性免疫反应
  • 批准号:
    8629318
  • 财政年份:
    2012
  • 资助金额:
    $ 36.19万
  • 项目类别:
Visualizing the innate and adaptive immune response to Listeria monocytogenes
可视化对单核细胞增生李斯特氏菌的先天和适应性免疫反应
  • 批准号:
    8996673
  • 财政年份:
    2012
  • 资助金额:
    $ 36.19万
  • 项目类别:
Visualizing the innate and adaptive immune response to Listeria monocytogenes
可视化对单核细胞增生李斯特氏菌的先天和适应性免疫反应
  • 批准号:
    8605831
  • 财政年份:
    2012
  • 资助金额:
    $ 36.19万
  • 项目类别:

相似海外基金

Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
  • 批准号:
    10836880
  • 财政年份:
    2023
  • 资助金额:
    $ 36.19万
  • 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
  • 批准号:
    10734324
  • 财政年份:
    2023
  • 资助金额:
    $ 36.19万
  • 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
  • 批准号:
    10740465
  • 财政年份:
    2023
  • 资助金额:
    $ 36.19万
  • 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
  • 批准号:
    23K04971
  • 财政年份:
    2023
  • 资助金额:
    $ 36.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
  • 批准号:
    2885451
  • 财政年份:
    2023
  • 资助金额:
    $ 36.19万
  • 项目类别:
    Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
  • 批准号:
    10385926
  • 财政年份:
    2022
  • 资助金额:
    $ 36.19万
  • 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
  • 批准号:
    10509043
  • 财政年份:
    2022
  • 资助金额:
    $ 36.19万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10704008
  • 财政年份:
    2022
  • 资助金额:
    $ 36.19万
  • 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
  • 批准号:
    10818273
  • 财政年份:
    2022
  • 资助金额:
    $ 36.19万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10349397
  • 财政年份:
    2022
  • 资助金额:
    $ 36.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了